Becton, Dickinson and Company · Class II · Cleared Aug 12, 2020
| K-number | K201099 |
| Device name | BD PhaSeal Optima Closed System Drug Transfer Device |
| Applicant | Becton, Dickinson and Company |
| Product code | ONB |
| Device class | Class II |
| Decision date | Aug 12, 2020 |
| Decision | Substantially Equivalent |
| Regulation | 880.5440 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov